83 related articles for article (PubMed ID: 15567628)
41. Missing... presumed at random: cost-analysis of incomplete data.
Briggs A; Clark T; Wolstenholme J; Clarke P
Health Econ; 2003 May; 12(5):377-92. PubMed ID: 12720255
[TBL] [Abstract][Full Text] [Related]
42. Missing inaction: preventing missing outcome data in randomized clinical trials.
Wittes J
J Biopharm Stat; 2009 Nov; 19(6):957-68. PubMed ID: 20183458
[TBL] [Abstract][Full Text] [Related]
43. Missing data handling methods in medical device clinical trials.
Yan X; Lee S; Li N
J Biopharm Stat; 2009 Nov; 19(6):1085-98. PubMed ID: 20183466
[TBL] [Abstract][Full Text] [Related]
44. The compliance score as a regressor in randomized trials.
Joffe MM; Ten Have TR; Brensinger C
Biostatistics; 2003 Jul; 4(3):327-40. PubMed ID: 12925501
[TBL] [Abstract][Full Text] [Related]
45. Effects of chiropractic treatment on blood pressure and anxiety: a randomized and controlled trial.
J Manipulative Physiol Ther; 1991 Jan; 14(1):74-7. PubMed ID: 2002292
[No Abstract] [Full Text] [Related]
46. A simple method for analyzing data from a randomized trial with a missing binary outcome.
Baker SG; Freedman LS
BMC Med Res Methodol; 2003 May; 3():8. PubMed ID: 12734019
[TBL] [Abstract][Full Text] [Related]
47. Ignorability and bias in clinical trials.
Heitjan DF
Stat Med; 1999 Sep 15-30; 18(17-18):2421-34. PubMed ID: 10474150
[TBL] [Abstract][Full Text] [Related]
48. Effects of chiropractic treatment on blood pressure and anxiety: a randomized and controlled trial.
Richards D
J Manipulative Physiol Ther; 1992; 15(3):210-2. PubMed ID: 1573350
[No Abstract] [Full Text] [Related]
49. Effect of non-random missing data mechanisms in clinical trials.
Choi SC; Lu IL
Stat Med; 1995 Dec; 14(24):2675-84. PubMed ID: 8619107
[TBL] [Abstract][Full Text] [Related]
50. Concerns about run-in periods in randomized trials.
Glynn RJ; Buring JE; Hennekens CH
JAMA; 1998 May; 279(19):1526; author reply 1527. PubMed ID: 9605892
[No Abstract] [Full Text] [Related]
51. Comprehensive/tertiary care for headache.
Jaffe R
Headache; 1999; 39(7):518-20. PubMed ID: 11279940
[No Abstract] [Full Text] [Related]
52. Commentary: Weighing up the dead and missing: reflections on inverse-probability weighting and principal stratification to address truncation by death.
Chaix B; Evans D; Merlo J; Suzuki E
Epidemiology; 2012 Jan; 23(1):129-31; discussion 132-7. PubMed ID: 22157307
[No Abstract] [Full Text] [Related]
53. Clinical trial of a new tranquilizer, prochlorperazine.
STEVENSON LE
Med Ann Dist Columbia; 1957 Dec; 26(12):633-6. PubMed ID: 13482500
[No Abstract] [Full Text] [Related]
54. [Clinical results in the use of a new anti-anxiety drug].
FIUME S; SASSANELLI G
Clin Ter; 1960 Sep; 19():267-76. PubMed ID: 13700088
[No Abstract] [Full Text] [Related]
55. For Health-Related Quality of Life and Other Longitudinal Data, Analysis Should Distinguish Between Truncation by Death and Data Missing Because of Nonresponse.
Kurland BF; Egleston BL
J Clin Oncol; 2016 Dec; 34(36):4449. PubMed ID: 27601541
[No Abstract] [Full Text] [Related]
56. Missing data in randomized controlled trials testing palliative interventions pose a significant risk of bias and loss of power: a systematic review and meta-analyses.
Hussain JA; White IR; Langan D; Johnson MJ; Currow DC; Torgerson DJ; Bland M
J Clin Epidemiol; 2016 Jun; 74():57-65. PubMed ID: 26718729
[TBL] [Abstract][Full Text] [Related]
57. Sequential FOLFIRI.3 + Gemcitabine Improves Health-Related Quality of Life Deterioration-Free Survival of Patients with Metastatic Pancreatic Adenocarcinoma: A Randomized Phase II Trial.
Anota A; Mouillet G; Trouilloud I; Dupont-Gossart AC; Artru P; Lecomte T; Zaanan A; Gauthier M; Fein F; Dubreuil O; Paget-Bailly S; Taieb J; Bonnetain F
PLoS One; 2015; 10(5):e0125350. PubMed ID: 26010884
[TBL] [Abstract][Full Text] [Related]
58. Factors associated with incomplete DASH questionnaires.
Bot AG; Ferree S; Neuhaus V; Ring D
Hand (N Y); 2013 Mar; 8(1):71-6. PubMed ID: 24426897
[TBL] [Abstract][Full Text] [Related]
59. Time to health-related quality of life score deterioration as a modality of longitudinal analysis for health-related quality of life studies in oncology: do we need RECIST for quality of life to achieve standardization?
Anota A; Hamidou Z; Paget-Bailly S; Chibaudel B; Bascoul-Mollevi C; Auquier P; Westeel V; Fiteni F; Borg C; Bonnetain F
Qual Life Res; 2015 Jan; 24(1):5-18. PubMed ID: 24277234
[TBL] [Abstract][Full Text] [Related]
60. Correspondence of patient word choice with psychologic factors in patients with upper extremity illness.
Bot AG; Vranceanu AM; Herndon JH; Ring DC
Clin Orthop Relat Res; 2012 Nov; 470(11):3180-6. PubMed ID: 22707072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
